Sugar substitutes, substance abuse, GLP-1 drugs, and the biggest clinical trials of the year—each had their place in our top ...

KL4 Surfactant is under clinical development by Windtree Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

After successfully resuscitated out-of-hospital cardiac arrest without ST-segment elevations, immediate coronary angiography ...

Shock new details - including Mam’s full traffic ... had less than 0.01mg/L of cocaine in his system after using the drug socially the day before the crash, which happened on October 18 when ...